CLINICAL_TRIALS
trial_result
· 2023-07-25
Clinical Trial Update: Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks [Phase 4]
Summary
Phase 4 clinical trial update on mifepristone with two doses of misoprostol for abortion at 11–12 weeks, terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gynuity Health Projects | Conditions: Medical Abortion | Phase 4 | Status: TERMINATED